Study guide

10.7 Proximal Femur Follow-Up Scans and Rate of Change

ARRT Bone Densitometry Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Orientation & the ARRT Blueprint

1.1 About the ARRT Bone Densitometry Examination 1.2 Eligibility, Structured Education, and Clinical Experience

2 Chapter 2: Osteoporosis, Bone Biology & Risk Factors

2.1 Osteoporosis: Definitions, Types, and WHO Diagnostic Criteria 2.2 Bone Functions, Structural Anatomy, and Bone Types 2.3 Bone Cells, the Remodeling Cycle, and Calcium Homeostasis 2.4 Risk Factors, Secondary Causes, and Bone-Compromising Medications

3 Chapter 3: Indications, Prevention & Treatment

3.1 The Bone Mass Measurement Act: Covered Indications and Coding 3.2 Prevention: Nutrition, Exercise, Smoking Cessation, and Fall Prevention 3.3 Osteoporosis Drug Therapy: Antiresorptive, Anabolic, and Hormonal Agents

4 Chapter 4: Patient Preparation, Support & Radiation Safety

4.1 Patient Support, Disabilities, Ergonomics, and Transfer Techniques 4.2 Patient Instructions: Explaining the Exam, Dose, Duration, and Motion Control 4.3 Patient History, Contraindications, and Pregnancy Screening 4.4 Scan Preparation: Patient Data Entry, Artifact Removal, and Infection Control 4.5 Radiation Safety in DXA: ALARA, Distance, and Dose Levels

5 Chapter 5: DXA Physics & Instrumentation

5.1 Physical Principles of Dual-Energy X-ray Absorptiometry 5.2 Beam Geometries: Pencil Beam and Fan Beam Systems 5.3 Fan-Beam Geometry: Source–Object–Detector Distances, Magnification, and Centering 5.4 The Scan Analysis Algorithm: Soft Tissue, Bone Edge Detection, BMC, Area, and BMD

6 Chapter 6: Measuring & Reporting Bone Mineral Density

6.1 Statistics for Densitometry: Mean, Standard Deviation, and Coefficient of Variation 6.2 T-Scores, Z-Scores, and Reference Database Selection 6.3 Clinical Indications for BMD Testing and the FRAX Tool 6.4 Vertebral Fracture Assessment and Trabecular Bone Score 6.5 Whole Body DXA, Body Composition, and Pediatric Scanning

7 Chapter 7: Quality Control, Precision & Equipment Management

7.1 Accuracy, Precision, and the Sources of Precision Error 7.2 Daily Quality Control, Phantoms, and Control Charts 7.3 In Vivo Precision Studies and RMS-SD Calculation 7.4 Determining and Applying the Least Significant Change 7.5 Maintenance, Repair, Relocation, Cross-Calibration, and Software Upgrades

8 Chapter 8: DXA Informatics & Data Management

8.1 DXA Informatics, DICOM, PACS, and Data Management

9 Chapter 9: Lumbar Spine DXA

9.1 Lumbar Spine Anatomy, Landmarks, and Regions of Interest 9.2 Lumbar Spine Scan Acquisition and ROI Edge Placement 9.3 Lumbar Spine: Compensating for Body Habitus, Variant Anatomy, Pathology, and Low Bone Density 9.4 Lumbar Spine Positioning: The Leg Block, Centering, and Common Challenges 9.5 Lumbar Spine Problems: Poor Bone Edge Detection and Obscured Intervertebral Spaces 9.6 Lumbar Spine: Variant Anatomy, Fractures, Degenerative Pathology, Calcification, and Surgery 9.7 Lumbar Spine Analysis: Vertebral Exclusion and Reporting Rules 9.8 Lumbar Spine Follow-Up Scans and Rate of Change

10 Chapter 10: Proximal Femur DXA

10.1 Proximal Femur Anatomy, Landmarks, and Regions of Interest 10.2 Femur Selection: Right, Left, and Dual Femur Scanning 10.3 Proximal Femur Scan Parameters and Compensation 10.4 Proximal Femur Positioning: Neck Rotation, Shaft Placement, and Positioning Aids 10.5 Proximal Femur Problems: Ischium, Short Neck, Arthritis, Fracture, and Hardware 10.6 Femoral ROI Analysis: Femoral Neck, Total Hip, and Ward's Area 10.7 Proximal Femur Follow-Up Scans and Rate of Change

11 Chapter 11: Forearm DXA

11.1 Forearm Anatomy, Landmarks, and Adjacent Structures 11.2 Forearm Indications and Side Selection 11.3 Forearm Length Measurement, Scan Parameters, and Positioning 11.4 Forearm Regions of Interest: One-Third, Mid, Ultradistal, and Total 11.5 Forearm Problems: Edge Detection, Artifacts, Low Bone Density, and Joint Disease 11.6 Scan Analysis: Region Placement, Window Level, and Reported Values 11.7 Forearm Follow-Up Scans and Rate of Change

12 Chapter 12: Cross-Site Artifacts & Clinical Integration

12.1 Recognition, Impact, and Management of DXA Artifacts 12.2 Clinical Interpretation, Serial Comparison, and Reporting

10.7 Proximal Femur Follow-Up Scans and Rate of Change

Key Takeaways Explain This Topic AI

Total hip is the preferred hip region for monitoring because its precision is better than the femoral neck, which improves the ability to detect real change.

Hip BMD typically changes by only 1 to 2% per year with antiresorptive therapy, so significant change takes longer to demonstrate than at the spine.

The same femur must be scanned at every visit, because right and left BMD differ and a side change makes the comparison meaningless.

Internal rotation must be reproduced, since a rotation difference between visits alters projected neck area and produces a purely geometric apparent change.

Ward's area and the trochanter alone must not be used for monitoring or for diagnostic classification.

Last updated: September 2026

10.7 Proximal Femur Follow-Up Scans and Rate of Change

Quick Answer: The hip changes slowly — roughly 1–2% per year under antiresorptive therapy versus 2–4% at the spine — so significant change takes longer to demonstrate. Total hip is preferred over femoral neck for monitoring because its precision is better (ISCD minimum 1.8% versus 2.5%). Reproduce the same side, the same rotation, the same shaft alignment, and the same ROI placement , and compare absolute BMD against the facility LSC.

Why the Hip Is Monitored Despite Being Slower

The hip changes less than the spine, which is a disadvantage for detecting change. It compensates in three ways:

Hip fracture is the outcome that matters most. Hip fractures carry the highest morbidity, mortality, and cost of any osteoporotic fracture, and hip BMD is the strongest single predictor of hip fracture.

The hip is not corrupted by spinal degenerative disease. In the older patient whose spine is inflated by osteophytes, sclerosis, and aortic calcification, the hip is often the only trustworthy site.

Total hip precision is good. Better precision partially offsets the smaller signal.

Total Hip Versus Femoral Neck for Monitoring

  • Total hip Femoral neck
  • Region Femoral neck + trochanteric + intertrochanteric Neck only
  • Area analyzed Larger Small
  • ISCD minimum acceptable precision 1.8% 2.5%
  • Sensitivity to rotation error Lower Higher
  • Preferred for monitoring Yes No
  • Valid for diagnosis Yes Yes

A larger ROI averages over more bone, so random placement and positioning variability contribute proportionally less. That is the entire reason total hip monitors better. The femoral neck remains a valid diagnostic site — and is the BMD input FRAX uses — but the total hip is what is tracked over time.

Ward's area and the trochanter alone are used for neither diagnosis nor monitoring. Ward's area is a small low-density region with poor precision; it will reliably produce the lowest number on the report and the least reliable one.

Reproducing the Baseline Femur Study

  • Element Requirement
  • Side Same femur, every time, without exception
  • Scanner and mode Same unit, same acquisition mode
  • Internal rotation Same achieved rotation, using the same positioner at the same setting
  • Shaft alignment Same parallel alignment; no new abduction or adduction
  • Scan field Same superior and inferior limits
  • ROI placement Same neck box position and angle; same global ROI boundaries
  • Manual edits Same edits reapplied, using the baseline analysis as reference
  • The Side Rule

Right and left femur BMD differ in most people, often by several percent, and there is no conversion between them. A baseline on the right and a follow-up on the left produces a difference that is anatomy, not biology.

Document the side prominently, and check it against the prior study before positioning — not after acquiring.

If the previously scanned hip becomes unmeasurable, because of a new fracture or an arthroplasty, the contralateral hip becomes a new baseline , not a continuation. Say so in the report.

The Rotation Rule

Rotation is the femur's largest precision lever. Under-rotation foreshortens the neck, shrinking projected area and raising BMD. A patient rotated correctly at baseline and under-rotated at follow-up will appear to have gained bone; the reverse appears as loss.

The practical defense is the same aid at the same setting plus a check of the lesser trochanter on both images. If the baseline image shows a prominent lesser trochanter and today's does not, the comparison is compromised even though today's scan is technically better. Note it.

Calculating Rate of Change

Worked example. Baseline total hip 0.745 g/cm²; follow-up at 24 months 0.769 g/cm²; facility total hip LSC 0.028 g/cm².

Δ BMD = 0.769 − 0.745 = + 0.024 g/cm 2 \Delta \text{BMD} = 0.769 - 0.745 = +0.024\ \text{g/cm}^2 Δ BMD = 0.769 − 0.745 = + 0.024 g/cm 2

0.024 < 0.028 0.024 < 0.028 0.024 < 0.028 , so the change is not statistically significant. Report stable bone density .

Percent change = 0.024 ÷ 0.745 × 100 = + 3.2 % = 0.024 \div 0.745 \times 100 = +3.2\% = 0.024 ÷ 0.745 × 100 = + 3.2% over two years.

Notice that a 3.2% rise is reported as no significant change at the hip. This is the practical reason hip monitoring intervals are longer: the biological signal at the hip is small relative to the LSC, so a two-year interval may still be insufficient to demonstrate significance.

Second example. Baseline femoral neck 0.690; follow-up 0.648; femoral neck LSC 0.035.

Δ = − 0.042 \Delta = -0.042 Δ = − 0.042 , and ∣ − 0.042 ∣ > 0.035 |-0.042| > 0.035 ∣ − 0.042∣ > 0.035 , so this is a significant decrease.

Percent change = − 0.042 ÷ 0.690 × 100 = − 6.1 % = -0.042 \div 0.690 \times 100 = -6.1\% = − 0.042 ÷ 0.690 × 100 = − 6.1% .

A loss of this magnitude at the hip prompts review: is the patient adherent to therapy, has a secondary cause emerged, has denosumab lapsed, and — technically — were both scans acquired with the same side, rotation, and ROI?

Reporting the Rate

Rate of change may be expressed as absolute change per year, percent change per year, or total change over the interval. All three are derived from absolute BMD , never from T-scores, because reference database and software changes move T-scores independently of the patient.

The ARRT specifications effective January 2027 name rate of change in BMD and in T-score and Z-score under follow-up scans. The distinction to hold is that T-score and Z-score trends may be reported descriptively , but the determination of whether change is real is made on absolute BMD against the LSC.

Timing

One to two years after initiating or changing therapy is the standard interval, and at the hip the longer end of that range is often more informative.

Six to twelve months in rapid-loss states: high-dose glucocorticoids, transplantation, immobilization.

Shorter than six months is rarely useful at the hip, because expected change is far below the LSC.

Once stability is documented on treatment, intervals lengthen further.